Radnor Capital Management LLC purchased a new position in shares of The Procter & Gamble Company (NYSE:PG – Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 32,939 shares of the company’s stock, valued at approximately $5,705,000. Procter & Gamble comprises 0.8% of Radnor Capital Management LLC’s investment portfolio, making the stock its 19th biggest holding.
Other hedge funds have also recently added to or reduced their stakes in the company. Acorn Creek Capital LLC grew its stake in shares of Procter & Gamble by 2.8% during the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock valued at $376,000 after acquiring an additional 59 shares during the period. Patrick M Sweeney & Associates Inc. grew its stake in shares of Procter & Gamble by 1.1% during the 3rd quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock valued at $963,000 after acquiring an additional 59 shares during the period. Alera Investment Advisors LLC grew its stake in shares of Procter & Gamble by 1.2% during the 1st quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock valued at $812,000 after acquiring an additional 60 shares during the period. Hudson Value Partners LLC grew its stake in shares of Procter & Gamble by 4.1% during the 2nd quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock valued at $250,000 after acquiring an additional 60 shares during the period. Finally, Traveka Wealth LLC grew its stake in shares of Procter & Gamble by 1.7% during the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock valued at $616,000 after acquiring an additional 60 shares during the period. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble Trading Up 0.4 %
Procter & Gamble stock opened at $165.79 on Wednesday. The stock has a 50-day moving average of $171.45 and a two-hundred day moving average of $168.18. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The Procter & Gamble Company has a one year low of $142.50 and a one year high of $177.94. The stock has a market cap of $390.44 billion, a PE ratio of 28.58, a price-to-earnings-growth ratio of 3.57 and a beta of 0.42.
Procter & Gamble Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a $1.0065 dividend. This represents a $4.03 annualized dividend and a dividend yield of 2.43%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s payout ratio is 69.48%.
Insider Activity at Procter & Gamble
In related news, CEO Jon R. Moeller sold 72,174 shares of Procter & Gamble stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $171.01, for a total transaction of $12,342,475.74. Following the completion of the transaction, the chief executive officer now directly owns 263,158 shares in the company, valued at approximately $45,002,649.58. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Procter & Gamble news, CEO Jon R. Moeller sold 31,797 shares of the firm’s stock in a transaction that occurred on Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total value of $5,380,688.34. Following the sale, the chief executive officer now directly owns 300,777 shares of the company’s stock, valued at approximately $50,897,483.94. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Jon R. Moeller sold 72,174 shares of the firm’s stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $171.01, for a total value of $12,342,475.74. Following the completion of the sale, the chief executive officer now directly owns 263,158 shares in the company, valued at approximately $45,002,649.58. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 385,771 shares of company stock worth $65,610,975. 0.18% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
PG has been the subject of several recent analyst reports. Evercore ISI upped their price target on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research note on Monday, October 21st. Piper Sandler initiated coverage on Procter & Gamble in a research note on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price target for the company. Royal Bank of Canada restated a “sector perform” rating and issued a $164.00 price target on shares of Procter & Gamble in a research note on Monday, October 21st. Deutsche Bank Aktiengesellschaft upped their price target on Procter & Gamble from $171.00 to $176.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Finally, TD Cowen began coverage on Procter & Gamble in a report on Tuesday, July 23rd. They set a “buy” rating and a $189.00 price objective on the stock. Nine research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $177.00.
View Our Latest Research Report on Procter & Gamble
Procter & Gamble Company Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Stories
- Five stocks we like better than Procter & Gamble
- How to Invest in the FAANG Stocks
- 2 Alternative Internet Stocks Staging a Breakout in 2024
- Why Invest in High-Yield Dividend Stocks?
- Discover the 3 Best-Performing Biotech IPO Stocks of 2024
- How to Read Stock Charts for Beginners
- Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.